I. Podglajen et al., MECHANISM OF RESISTANCE TO CARBAPENEM IN CLINICAL ISOLATES OF BACTEROIDES-FRAGILIS, Medecine et maladies infectieuses, 24, 1994, pp. 590-593
Carbapenem (imipenem [IMI], meropenem [MER]) resistance in clinical is
olates of Bacteroides fragilis is due to the production of a carbapene
mase, a Zn++-dependent metallo beta-lactamase, encoded by the gene cfi
A. This gene is carried by ca. 3 % of the B. fragilis strains isolated
in France, but is expressed (MICs of IMI, MER greater-than-or-equal-t
o 64 mug/ml) in only one third of the cases, and silent (MICs of IMI/M
ER = 1/2 mug/ml) in the remaining two thirds. Activation of the silent
gene occurs, in vitro and in vivo, after insertion of an IS element,
most frequently IS1186, carrying a strong promoter, immediately upstre
am of the gene. The cfiA-positive strains differ from the cfiA-negativ
e strains in that they harbor the IS elements known in B. fragilis (IS
4351, IS1186, IS942) and they constitute, on the basis of molecular ty
ping and sequencing of 16S RNA genes, a distinct taxonomical unit.